-
Cy3 RNA Labeling Kit: Practical Workflow Guide
2026-09-23
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus supports in vitro transcription of randomly Cy3-modified RNA probes for fluorescence-based hybridization workflows. It is intended for research applications such as in situ hybridization and Northern blotting, not diagnostic, medical, or therapeutic use.
-
CAF–ANGPTL4–IQGAP1 Axis in Prostate Cancer
2026-09-23
The reference study identifies a cancer-associated fibroblast (CAF) mechanism that links paracrine ANGPTL4 signaling to IQGAP1, mitochondrial biogenesis, oxidative phosphorylation, and reduced chemotherapy sensitivity in prostate cancer. Its integrated proteomic, metabolomic, biochemical, and pharmacological approach provides a framework for studying tumor–stroma metabolic crosstalk while highlighting the need for further validation in clinically representative models.
-
Ibuprofen Workflows for Cancer Cell Research
2026-09-22
Build more informative Ibuprofen experiments by linking COX biology with viability, apoptosis, and cell-cycle measurements. This workflow emphasizes solubility control, protein-binding-aware interpretation, and p53-stratified colon cancer research rather than relying on a single endpoint.
-
Cholesterol in mRNA-LNP Membrane Workflows
2026-09-21
Cholesterol B1702 provides a controlled sterol variable for membrane fluidity assays, lipid metabolism research, and mRNA-LNP development. This practical guide connects the localized p21 mRNA-LNP bladder cancer study with solvent handling, formulation screens, assay controls, and troubleshooting decisions without implying that the reference study directly tested cholesterol.
-
Sulfo-Cy3 NHS Ester for Translational Vascular Research
2026-09-21
A mechanistic and strategic guide to using Sulfo-Cy3 NHS ester in vascular biology, with emphasis on the AIBP–LRP2–HDL–miR-223–CXCR4 axis, protein labeling quality, translational validation, and experimental decision-making.
-
Albiflorin Suppresses RCC via EGFR/MAPK Signaling
2026-09-20
A 2026 study integrated cell-based assays, network pharmacology, molecular docking, and pathway-rescue experiments to examine albiflorin in renal cell carcinoma. The evidence supports inhibition of RCC cell proliferation and migration, with EGFR/MAPK signaling emerging as a mechanistically relevant axis rather than a definitively established direct target.
-
Metformin Beyond Glucose: A Translational HO Strategy
2026-09-19
Metformin is emerging as more than a glucose-lowering research tool. This thought-leadership article examines how its metabolic actions intersect with Nr4a1/Wnt/β-catenin signaling in heterotopic ossification and provides a practical framework for translational validation.
-
Tacrine Hydrochloride Hydrate in AD Research
2026-09-19
Tacrine hydrochloride hydrate is more than a legacy cholinesterase inhibitor: it is a compact mechanistic probe for connecting acetylcholine biology, amyloid and tau pathology, assay design, and translational risk. This article explains how to use the compound strategically in Alzheimer’s disease research while keeping its hepatotoxicity history central to interpretation.
-
Biotin (Vitamin B7) for Assay Workflows
2026-09-18
Biotin (Vitamin B7) connects metabolic enzyme studies with highly modular avidin–streptavidin detection workflows. This guide shows how to prepare the product, distinguish free biotin from activated biotinylation reagents, and adapt biotin-based controls to nucleic-acid sensing assays inspired by shrimp STING research.
-
Ozone, Efferocytosis, and Neuropathic Pain
2026-09-18
The 2024 Frontiers in Immunology study identifies impaired apoptotic-cell clearance as a modifiable component of neuropathic pain and links ozone treatment to AMPK/Gas6-MerTK/SOCS3 signaling in macrophages. Its combination of a chronic constriction injury model, bone-marrow-derived macrophage assays, and pathway inhibitors provides a mechanistic framework for connecting efferocytosis with reduced neuroinflammation and pain hypersensitivity.
-
SB 202190: A Cell-Fate Assay Strategy
2026-09-17
SB 202190 is a selective p38 MAP kinase inhibitor that can reveal how stress signaling intersects with RIPK1-dependent apoptosis and necroptosis. This guide focuses on causal assay design, pathway controls, and interpretation rather than repeating a general product overview.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-17
Build a two-dimensional mRNA delivery readout by tracking Cy5 signal for cargo uptake and EGFP for productive translation. This workflow helps distinguish delivery failure from endosomal retention, RNA degradation, or weak expression while supporting nanoparticle validation and macrophage-focused studies.
-
Elobixibat Hydrate: From IBAT to Peristalsis
2026-09-16
A translational perspective on how Elobixibat hydrate links ileal bile acid transport, colonic signaling, peristaltic physiology, and indication-specific research strategy.
-
Reserpine (N1867): Practical Lab Workflow
2026-09-15
Reserpine (SKU N1867) provides a defined research reagent for neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows when direct matched paper evidence is unavailable. This guide addresses identity confirmation, DMSO-based preparation, storage, and QC while emphasizing that the material is for research use only, not for diagnostic, therapeutic, or medical applications.
-
Octenidine: Translational Antisepsis by Design
2026-09-15
A mechanistic and strategic guide to using Octenidine dihydrochloride as a membrane-targeting antiseptic research compound, with evidence-based workflow recommendations and perspective from next-generation gemini quaternary ammonium compounds.